Intramuscular vs intravaginal natural progesterone in patients undergoing in vitro fertilization-embryo transfer cycles. A retrospective observational, case-control study.
To compare the effectiveness of intramuscular (IM) and intravaginal (IV) progesterone for luteal phase support, in patients undergoing in vitro fertilization-embryo transfer cycles (IVF-ET). retrospective, observational, case-control study Centro Natalità, San Raffaele Hospital, Milan, Italy, from July 2007 to June 2009. 172 A-GnRH down-regulated IVF-ET cycles in patients with age < 40 years. Luteal phase support with IM progesterone (50 mg daily) or IV progesterone (90 mg daily). Biochemical pregnancy, clinical pregnancy, miscarriage, ongoing pregnancy rates and patient's acceptability. IM progesterone conferred more benefit compared with IV progesterone in terms of ongoing pregnancy rate (24.4% vs 12.7%; P < 0.05). In standard IVF cycles, our data showed that IM progesterone appears to be more effective at providing luteal support, thus rendering with IV progesterone.